REG4 expression was significantly higher in benign tumors, borderline tumors and primary cancer than that in normal ovarian tissue (P < 0.05; Table 1), while there was no significant difference between primary and metastatic cancers in the omentum (P = 0.076; Table 1). Here, REG4 is linked to metastatic malignant neoplasm.